The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Targeting the bone marrow microenvironment in multiple myeloma
Open accessAbstract
Summary: Multiple myeloma (MM) is characterized by clonal expansion of malignant plasma cells in the bone marrow (BM). Despite the significant advances in treatment, MM is still a fatal malignancy. This is mainly due to the supportive role of the BM microenvironment in differentiation, migration, proliferation, survival, and drug resistance of the malignant plasma cells. The BM microenvironment is composed of a cellular compartment (stromal cells, osteoblasts, osteoclasts, endothelial cells, and immune cells) and a non‐cellular compartment. In this review, we discuss the interaction between the malignant plasma cell and the BM microenvironment and the strategy to target them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Improved survival in multiple myeloma and the impact of novel therapies
Kumar, S. K., Rajkumar, S. V., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Zeldenrust, S. R., Dingli, D., Russell, S. J., Lust, J. A., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116129 · Cited by 2,240
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Regulatory T cells in tumor immunity
Nishikawa, H., & Sakaguchi, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25429 · Cited by 944
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Self-citationSelective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease
Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., & Sparwasser, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061852 · Cited by 924
Davies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Self-citationLutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H. (2005) · Blood · doi:10.1182/blood-2004-06-2410 · Cited by 903
Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
Kyle, R. A., Durie, B. G. M., Rajkumar, S. V., Landgren, O., Blade, J., Merlini, G., Kröger, N., Einsele, H., Vesole, D. H., Dimopoulos, M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.60 · Cited by 888
Self-citationGhiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., & Martin, F. (2004) · European Journal of Immunology · doi:10.1002/eji.200324181 · Cited by 880
Kyle, R. A., & Rajkumar, S. V. (2008) · Blood · doi:10.1182/blood-2007-10-078022 · Cited by 855
Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271874 · Cited by 807
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K., Tai, Y.-T., Reagan, M., Azab, F., Flores, L. M., Campigotto, F., Weller, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66517 · Cited by 794
Self-citationWalter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2883 · Cited by 788
The role of Notch in tumorigenesis: oncogene or tumour suppressor?
Radtke, F., & Raj, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1186 · Cited by 785
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
O’Doherty, U., Peng, M., Gezelter, S., Swiggard, W. J., Betjes, M. G. H., Bhardwaj, N., & Steinman, R. M. (1994) · PubMed Central · Cited by 601
Advances in biology of multiple myeloma: clinical applications
Hideshima, T., Bergsagel, P. L., Kuehl, W. M., & Anderson, K. C. (2004) · Blood · doi:10.1182/blood-2004-01-0037 · Cited by 582
Self-citationLiu, J., Hamrouni, A., Wolowiec, D., Coiteux, V., Kuliczkowski, K., Hetuin, D., Saudemont, A., & Quesnel, B. (2007) · Blood · doi:10.1182/blood-2006-10-051482 · Cited by 580
Dankbar, B., Padró, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R. M., Serve, H., Berdel, W. E., & Kienast, J. (2000) · Blood · doi:10.1182/blood.v95.8.2630 · Cited by 566
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544
Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., Bremond, A., Goddard, S., Pin, J.-J., Barthelemy-Dubois, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0684 · Cited by 460
Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B., & Shaughnessy, J. D. (2007) · Blood · doi:10.1182/blood-2006-09-047712 · Cited by 433
Azab, A. K., Runnels, J. M., Pitsillides, C., Moreau, A.-S., Azab, F., Leleu, X., Jia, X., Wright, R., Ospina, B., Carlson, A. L., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186668 · Cited by 428
Self-citationBroder, S. E., Humphrey, R. L., Durm, M., Blackman, M. A., Meade, B. D., Goldman, C. K., Strober, W., & Waldmann, T. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510302931801 · Cited by 419
Uchiyama, H., Barut, B., Mohrbacher, A., Chauhan, D., & Anderson, K. (1993) · Blood · doi:10.1182/blood.v82.12.3712.3712 · Cited by 418
Self-citationAnti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y.-T., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 399
Self-citationPathogenesis of myeloma bone disease
Roodman, G. D. (2009) · Leukemia · doi:10.1038/leu.2008.336 · Cited by 398
Görgün, G. T., Whitehill, G., Anderson, J. L., Hideshima, T., Maguire, C., Laubach, J., Raje, N., Munshi, N. C., Richardson, P. G., & Anderson, K. C. (2013) · Blood · doi:10.1182/blood-2012-08-448548 · Cited by 393
Self-citationGalustian, C., Meyer, B., Labarthe, M.-C., Dredge, K., Klaschka, D., Henry, J., Todryk, S., Chen, R., Muller, G., Stirling, D., et al. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0620-4 · Cited by 391
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)07003-x · Cited by 386
Brown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., & Joshua, D. (2001) · Blood · doi:10.1182/blood.v98.10.2992 · Cited by 347
Meyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108121108 · Cited by 346
Immunodeficiency and immunotherapy in multiple myeloma
Pratt, G., Goodyear, O., & Moss, P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06705.x · Cited by 341
Solito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S., Basso, G., Zanovello, P., Onicescu, G., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325753 · Cited by 337
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., Danho, C., Laharrague, P., Klein, B., Rème, T., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404621 · Cited by 328
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
Garrett, I. R., Chen, D., Gutierrez, G., Zhao, M., Escobedo, A., Rossini, G., Harris, S. E., Gallwitz, W., Kim, K. B., Hu, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16198 · Cited by 328
Hayashi, T., Hideshima, T., Akiyama, M., Podar, K., Yasui, H., Raje, N., Kumar, S., Chauhan, D., Treon, S. P., Richardson, P., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05286.x · Cited by 323
Self-citationTyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals
Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R. S., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.037 · Cited by 321
McMillin, D. W., Delmore, J., Weisberg, E., Negri, J. M., Geer, D. C., Klippel, S., Mitsiades, N., Schlossman, R. L., Munshi, N. C., Kung, A. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2112 · Cited by 315
Self-citationConrad, C., Gregorio, J., Wang, Y.-H., Ito, T., Meller, S., Hanabuchi, S., Anderson, S., Atkinson, N., Ramirez, P. T., Liu, Y.-J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2271 · Cited by 314
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
Zheng, Y., Cai, Z., Wang, S., Zhang, X., Qian, J., Hong, S., Li, H., Wang, M., Yang, J., & Yi, Q. (2009) · Blood · doi:10.1182/blood-2009-05-220285 · Cited by 307
Yaccoby, S., Pearse, R. N., Johnson, C. L., Barlogie, B., Choi, Y., & Epstein, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03257.x · Cited by 305
Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M. R., Knolle, P. A., Classen, S., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2005-09-3671 · Cited by 301
Azab, A. K., Hu, J., Quang, P., Azab, F., Pitsillides, C., Awwad, R., Thompson, B., Maiso, P., Sun, J. D., Hart, C. P., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380410 · Cited by 301
Self-citationRajkumar, S. V., Mesa, R. A., Fonseca, R., Schroeder, G. S., Plevak, M. F., Dispenzieri, A. A., Lacy, M. Q., Lust, J. A., Witzig, T. E., Gertz, M. A., et al. (2002) · PubMed · Cited by 287
Chauhan, D., Singh, A. V., Brahmandam, M., Carrasco, R., Bandi, M., Hideshima, T., Bianchi, G., Podar, K., Tai, Y.-T., Mitsiades, C., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.019 · Cited by 286
Self-citationRoccaro, A. M., Hideshima, T., Raje, N., Kumar, S., Ishitsuka, K., Yasui, H., Shiraishi, N., Ribatti, D., Nico, B., Vacca, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1195 · Cited by 284
Self-citationRosenblatt, J., Glotzbecker, B., Mills, H., Vasir, B., Tzachanis, D., Levine, J. D., Joyce, R. M., Wellenstein, K., Keefe, W., Schickler, M., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31821ca6ce · Cited by 283
Engineered nanomedicine for myeloma and bone microenvironment targeting
Swami, A., Reagan, M. R., Basto, P., Mishima, Y., Kamaly, N., Glavey, S., Zhang, S., Moschetta, M., Seevaratnam, D., Zhang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401337111 · Cited by 283
Self-citationNefedova, Y., Cheng, P., Alsina, M., Dalton, W. S., & Gabrilovich, D. I. (2004) · Blood · doi:10.1182/blood-2003-07-2340 · Cited by 270
Klages, K., Mayer, C. T., Lahl, K., Loddenkemper, C., Teng, M. W. L., Ngiow, S. F., Smyth, M. J., Hamann, A., Huehn, J., & Sparwasser, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1736 · Cited by 267
Jinushi, M., Vanneman, M., Munshi, N. C., Tai, Y.-T., Prabhala, R. H., Ritz, J., Neuberg, D., Anderson, K. C., Carrasco, D. R., & Dranoff, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711293105 · Cited by 256
Self-citationBataille, R., Chappard, D., Marcelli, C., Dessauw, P., Sany, J., Baldet, P., & Alexandre, C. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1909 · Cited by 241
Shipman, C. M., & Croucher, P. I. (2003) · PubMed · Cited by 241
Cannito, S., Novo, E., di Bonzo, L. V., Busletta, C., Colombatto, S., & Parola, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2737 · Cited by 239
Dysfunctional T regulatory cells in multiple myeloma
Prabhala, R. H., Neri, P., Bae, J. E., Tassone, P., Shammas, M. A., Allam, C. K., Daley, J. F., Chauhan, D., Blanchard, E., Thatte, H. S., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3101 · Cited by 239
Self-citationMukherjee, S., Raje, N., Schoonmaker, J. A., Liu, J. C., Hideshima, T., Wein, M. N., Jones, D. C., Vallet, S., Bouxsein, M. L., Pozzi, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33102 · Cited by 238
Self-citationTamura, H., Ishibashi, M., Yamashita, T., Tanosaki, S., Okuyama, N., Kondo, A., Hyodo, H., Shinya, E., Takahashi, H., Dong, H., et al. (2013) · Leukemia · doi:10.1038/leu.2012.213 · Cited by 225
Eckhardt, B. L., Parker, B. S., van Laar, R. K., Restall, C. M., Natoli, A. L., Tavaria, M. D., Stanley, K. L., Sloan, E. K., Moseley, J. M., & Anderson, R. L. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.1.3.1 · Cited by 224
Faget, J., Bendriss-Vermare, N., Gobert, M., Durand, I., Olive, D., Biota, C., Bachelot, T., Treilleux, I., Goddard-Leon, S., Lavergne, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2409 · Cited by 217
Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. E., & Svane, I. M. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02463.x · Cited by 215
Chesi, M., Matthews, G. M., Garbitt, V. M., Palmer, S. E., Shortt, J., Lefebure, M., Stewart, A. K., Johnstone, R. W., & Bergsagel, P. L. (2012) · Blood · doi:10.1182/blood-2012-02-412783 · Cited by 214
Ramachandran, I. R., Martner, A., Pisklakova, A., Condamine, T., Chase, T., Vogl, T., Roth, J., Gabrilovich, D., & Nefedova, Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203373 · Cited by 210
Hung, J.-J., Yang, M.-H., Hsu, H.-S., Hsu, W.-H., Liu, J.-S., & Wu, K.-J. (2009) · Thorax · doi:10.1136/thx.2009.115691 · Cited by 207
Novel therapies targeting the myeloma cell and its bone marrow microenvironment
HIDESHIMA, T. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90033-8 · Cited by 201
Robertson, J. D., Nagesh, K., Jowitt, S. N., Dougal, M., Anderson, H., Mutton, K., Zambon, M., & Scarffe, J. H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1088 · Cited by 199
Teng, M. W. L., Ngiow, S. F., von Scheidt, B., McLaughlin, N., Sparwasser, T., & Smyth, M. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1681 · Cited by 192
Myeloma as a model for the process of metastasis: implications for therapy
Ghobrial, I. M. (2012) · Blood · doi:10.1182/blood-2012-01-379024 · Cited by 188
Self-citationEndothelial cells in the bone marrow of patients with multiple myeloma
Vacca, A. (2003) · Blood · doi:10.1182/blood-2003-04-1338 · Cited by 180
Sandel, M. H., Dadabayev, A. R., Menon, A. G., Morreau, H., Melief, C. J. M., Offringa, R., van der Burg, S. H., Janssen-van Rhijn, C. M., Ensink, N. G., Tollenaar, R. A. E. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1448 · Cited by 173
Ribatti, D., Vacca, A., Nico, B., Fanelli, M., Roncali, L., & Dammacco, F. (1996) · European Journal of Haematology · doi:10.1111/j.1600-0609.1996.tb00293.x · Cited by 172
Pessoa de Magalhaes, R. J., Vidriales, M.-B., Paiva, B., Fernandez-Gimenez, C., Garcia-Sanz, R., Mateos, M.-V., Gutierrez, N. C., Lecrevisse, Q., Blanco, J. F., Hernandez, J., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.067272 · Cited by 171
Tai, Y.-T., Li, X.-F., Catley, L., Coffey, R., Breitkreutz, I., Bae, J., Song, W., Podar, K., Hideshima, T., Chauhan, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1657 · Cited by 167
Self-citationTumour-associated macrophages and cancer
Cook, J., & Hagemann, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.017 · Cited by 165
Tai, Y.-T., Chang, B. Y., Kong, S.-Y., Fulciniti, M., Yang, G., Calle, Y., Hu, Y., Lin, J., Zhao, J.-J., Cagnetta, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-396853 · Cited by 165
Self-citationAngiogenesis in multiple myeloma
Jakob, C., Sterz, J., Zavrski, I., Heider, U., Kleeberg, L., Fleissner, C., Kaiser, M., & Sezer, O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.02.017 · Cited by 162
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment
Heider, U., Kaiser, M., Müller, C., Jakob, C., Zavrski, I., Schulz, C., Fleissner, C., Hecht, M., & Sezer, O. (2006) · European Journal of Haematology · doi:10.1111/j.1600-0609.2006.00692.x · Cited by 161
Edwards, C. M., Edwards, J. R., Lwin, S. T., Esparza, J., Oyajobi, B. O., McCluskey, B., Munoz, S., Grubbs, B., & Mundy, G. R. (2008) · Blood · doi:10.1182/blood-2007-03-077685 · Cited by 160
Zheng, Y., Yang, J., Qian, J., Qiu, P., Hanabuchi, S., Lu, Y., Wang, Z., Liu, Z., Li, H., He, J., et al. (2012) · Leukemia · doi:10.1038/leu.2012.272 · Cited by 153
Dendritic cells associated with plasmablast survival
Vinuesa, C. G., Gulbranson‐Judge, A., Khan, M., O’Leary, P., Cascalho, M., Wabl, M. R., Klaus, G. G. B., Owen, M. J., & MacLennan, I. C. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3712::aid-immu3712>3.0.co;2-p · Cited by 153
Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
Hallett, W. H. D., Jing, W., Drobyski, W. R., & Johnson, B. D. (2011) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.03.011 · Cited by 152
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
Hu, J., Handisides, D. R., Valckenborgh, E. V., Raeve, H. D., Menu, E., Broek, I. V., Liu, Q., Sun, J. D., Camp, B. V., Hart, C. P., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269126 · Cited by 152
Expression of VEGF and its receptors by myeloma cells
Kumar, S. K., Witzig, T. E., Timm, M., Haug, J., Wellik, L. E., Fonseca, R., Greipp, P. R., & Rajkumar, S. V. (2003) · Leukemia · doi:10.1038/sj.leu.2403084 · Cited by 151
Kumar, S. K., Witzig, T. E., Timm, M., Haug, J. L., Wellik, L. E., Kimlinger, T. K., Greipp, P. R., & Rajkumar, S. V. (2004) · Blood · doi:10.1182/blood-2003-11-3811 · Cited by 146
Feyler, S., Lilienfeld‐Toal, M. V., Jarmin, S. J., Marles, L., Rawstron, A. C., Ashcroft, A. J., Owen, R. G., Selby, P. J., & Cook, G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07530.x · Cited by 146
Induction of angiogenesis by normal and malignant plasma cells
Hose, D., Moreaux, J., Meißner, T., Seckinger, A., Goldschmidt, H., Benner, A., Mahtouk, K., Hillengaß, J., Reme, T. X., Vos, J. D., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184226 · Cited by 143
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
Martin, S. K., Diamond, P., Gronthos, S., Peet, D. J., & Zannettino, A. C. W. (2011) · Leukemia · doi:10.1038/leu.2011.122 · Cited by 141
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
Kukreja, A., Hutchinson, A., Dhodapkar, K. M., Mazumder, A., Vesole, D. H., Angitapalli, R., Jagannath, S., & Dhodapkar, M. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052136 · Cited by 135
Vacca, A., Scavelli, C., Montefusco, V., Pietro, G. D., Neri, A., Mattioli, M., Bicciato, S., Nico, B., Ribatti, D., Dammacco, F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.723 · Cited by 132
Vacca, A., Loreto, M. D., Ribatti, D., Stefano, R. D., Gadaleta‐Caldarola, G., Iodice, G., Caloro, D., & Dammacco, F. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830500103 · Cited by 131
Angiogenesis and Multiple Myeloma
Giuliani, N., Storti, P., Bolzoni, M., Palma, B. D., & Bonomini, S. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0072-9 · Cited by 129
Raja, K. R. M., Říhová, L., Zahradová, L., Klincová, M., Penka, M., & Hájek, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047077 · Cited by 125
Kim, J., Denu, R. A., Dollar, B. A., Escalante, L. E., Kuether, J. P., Callander, N. S., Asimakopoulos, F. A., & Hematti, P. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09154.x · Cited by 124
Giannopoulos, K., Kamińska, W., Hus, I., & Dmoszyńska, A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.575 · Cited by 123
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Zhuang, J., Zhang, J., Lwin, S. T., Edwards, J., Edwards, C. M., Mundy, G. R., & Yang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048871 · Cited by 123
de Weers, M., Mensink, R. G. J., Kraakman, M. E. M., Schuurman, R. K. B., & Hendriks, R. W. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.1.161 · Cited by 123
Markovina, S. S., Callander, N. S., O’Connor, S. L., Xu, G., Shi, Y., Leith, C. P., Kim, K., Trivedi, P., Kim, J., Hematti, P., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-176 · Cited by 117
Hao, M., Zhang, L., An, G., Meng, H., Han, Y.-J., Xie, Z., Xu, Y., Li, C., Yu, Z., Chang, H. H., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.576791 · Cited by 116
Favaloro, J., Liyadipitiya, T., Brown, R. D., Yang, S., Suen, H., Woodland, N., Nassif, N. T., Hart, D. N. J., Fromm, P. D., Weatherburn, C., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.904511 · Cited by 113
Rushworth, S. A., Bowles, K. M., Barrera, L. N., Murray, M. Y., Zaitseva, L., & MacEwan, D. J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.008 · Cited by 110
Corre, J., Labat, E., Espagnolle, N., Hébraud, B., Avet‐Loiseau, H., Roussel, M., Huynh, A., Gadelorge, M., Cordelier, P., Klein, B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0188 · Cited by 106
Lioznov, M. V., Cheikh, J. E., Hoffmann, F. A., Hildebrandt, Y., Ayuk, F. A., Wolschke, C., Atanackovic, D., Schilling, G., Badbaran, A., Bacher, U., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.155 · Cited by 104
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
Ria, R., Todoerti, K., Berardi, S., Coluccia, A. M. L., Luisi, A. D., Mattioli, M., Ronchetti, D., Morabito, F., Guarini, A., Petrucci, M. T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0040 · Cited by 103
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma
Ehrlich, L. A., & Roodman, G. D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00323.x · Cited by 100
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
Hope, C. L., Ollar, S. J., Héninger, E., Hebron, E., Jensen, J. L., Kim, J., Maroulakou, I. G., Miyamoto, S., Leith, C. P., Yang, D. T., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554071 · Cited by 98
Ramos, R. N., Chin, L. S., dos Santos, A. P. S. D. A., Bergami-Santos, P. C., Laginha, F. M., & Barbuto, J. A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112048 · Cited by 98
Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma
Brimnes, M. K., Svane, I. M., & Johnsen, H. E. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03037.x · Cited by 96
Kearl, T. J., Jing, W., Gershan, J. A., & Johnson, B. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202005 · Cited by 92
HIF-1α determines the metastatic potential of gastric cancer cells
Rohwer, N., Lobitz, S., Daskalow, K., Jöns, T., Vieth, M. W., Schlag, P. M., Kemmner, W., Wiedenmann, B., Cramer, T., & Höcker, M. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604919 · Cited by 89
Tanno, T., Lim, Y., Wang, Q., Chesi, M., Bergsagel, P. L., Matthews, G., Johnstone, R. W., Ghosh, N., Borrello, I., Huff, C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-524025 · Cited by 84
Deleu, S., Lemaire, M., Arts, J., Menu, E., Valckenborgh, E. V., Broek, I. V., Raeve, H. D., Coulton, L. A., Camp, B. V., Croucher, P. I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4472 · Cited by 79
Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts
Karadağ, A., Oyajobi, B. O., Apperley, Russell, R. G. G., & Croucher, P. I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01845.x · Cited by 78
Liang, X., Zheng, M. H., Jiang, J. D., Zhu, G., Yang, J., & Tang, Y. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.11.014 · Cited by 75
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
Berardi, S., Ria, R., Reale, A., Luisi, A. D., Catacchio, I., Moschetta, M., & Vacca, A. (2013) · Journal of Oncology · doi:10.1155/2013/183602 · Cited by 70
Self-citationCretu, A., & Brooks, P. C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21222 · Cited by 67
Prognostic Potential Of The Pretherapeutic Tumor Oxygenation Status
Vaupel, P. W. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-85998-9_36 · Cited by 66
Hu, J., Valckenborgh, E. V., Xu, D., Menu, E., Raeve, H. D., Bryune, E. D., Xu, S., Camp, B. V., Handisides, D. R., Hart, C. P., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0123 · Cited by 61
Significantly reduced regulatory T cell population in patients with untreated multiple myeloma
Gupta, R., Ganesan, P., Hakim, M., Verma, R. K., Sharma, A., & Kumar, L. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.010 · Cited by 56
Kawano, Y., Kikukawa, Y., Fujiwara, S., Wada, N. A., Okuno, Y., Mitsuya, H., & Hata, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2134 · Cited by 56
Self-citationSlany, A., Haudek‐Prinz, V. J., Meshcheryakova, A., Bileck, A., Lamm, W. W., Zielinski, C. C., Gerner, C., & Drach, J. W. (2013) · Journal of Proteome Research · doi:10.1021/pr400881p · Cited by 52
Ray, A., Tian, Z., Das, D. S., Coffman, R. L., Richardson, P. G. G., Chauhan, D., & Anderson, K. C. (2014) · Leukemia · doi:10.1038/leu.2014.46 · Cited by 50
Self-citationPathogenesis and management of myeloma bone disease
Christoulas, D., Terpos, E., & Dimopoulos, M. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.36 · Cited by 46
Bone Marrow Stromal Cells From Myeloma Patients Support the Growth of Myeloma Stem Cells
Feng, Y., Wen, J., Mike, P., Choi, D. S., Eshoa, C., Shi, Z.-Z., Zu, Y., & Chang, C.-C. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0010 · Cited by 39
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity
Frassanito, M. A., Silvestris, F., Cafforio, P., Silvestris, N., & Dammacco, F. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02827242 · Cited by 38
Berardi, S., Caivano, A., Ria, R., Nico, B., Savino, R., Terracciano, R., Tullio, G. D., Ferrucci, A., Luisi, A. D., Moschetta, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.412 · Cited by 37
Self-citationAngiogenesis and Vasculogenesis in Multiple Myeloma: Role of Inflammatory Cells
Vacca, A., & Ribatti, D. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-85772-3_4 · Cited by 31
Macrophages in multiple myeloma
Ribatti, D., Moschetta, M., & Vacca, A. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.12.010 · Cited by 31
Self-citationChemoimmunotherapy Reduces the Progression of Multiple Myeloma in a Mouse Model
Sharabi, A., Laronne, A., Meshorer, A., & Haran‐Ghera, N. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0138 · Cited by 30
Laronne, A., Zipori, D., & Haran‐Ghera, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3714 · Cited by 27
Sawanobori, M., Suzuki, K., Nakagawa, Y., Inoue, Y., Utsuyam, M., & Hirokaw, K. (2009) · Acta Haematologica · doi:10.1159/000203610 · Cited by 26
Cited by
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9789 · Cited by 1,001
Malard, F., Neri, P., Bahlis, N. J., Terpos, E., Moukalled, N., Hungria, V. T. M., Manier, S., & Mohty, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00529-7 · Cited by 337
Self-citationCho, S.-F., Anderson, K. C., & Tai, Y.-T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01821 · Cited by 294
Self-citationPathogenesis beyond the cancer clone(s) in multiple myeloma
Bianchi, G., & Munshi, N. C. (2015) · Blood · doi:10.1182/blood-2014-11-568881 · Cited by 288
CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Marlein, C. R., Piddock, R. E., Mistry, J. J., Zaitseva, L., Hellmich, C., Horton, R. H., Zhou, Z., Auger, M. J., Bowles, K. M., & Rushworth, S. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0773 · Cited by 264
Metadata
- Authors
- Kawano, Y., Moschetta, M., Manier, S., Glavey, S., Görgün, G. T., Roccaro, A. M., Anderson, K. C., & Ghobrial, I. M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2014-12-15
- Volume
- 263
- Issue
- 1
- Pages
- 160-172
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1977328011
- Cited by
- 391
- References
- 161
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.